Grantham, Mayo, Van Otterloo & Co (GMO)’s Frontline FRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-61,662
Closed -$557K 711
2021
Q2
$557K Sell
61,662
-105,483
-63% -$849K ﹤0.01% 607
2021
Q1
$1.23M Buy
+167,145
New +$1.15M 0.01% 562
2020
Q4
Sell
-555,500
Closed -$3.61M 830
2020
Q3
$3.61M Sell
555,500
-407,200
-42% -$3.12M 0.03% 289
2020
Q2
$6.72M Buy
+962,700
New +$8.17M 0.05% 196

Other funds holding FRO

Grantham, Mayo, Van Otterloo & Co (GMO)'s FRO Position: Q3 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Frontline (FRO) in Q3 2021, closing a stake of 61,662 shares — an estimated $557K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in FRO in Q2 2020 and held it in 4 quarters. The position peaked at $6.72M in Q2 2020. 123 funds tracked by Wall St. Rank hold FRO as of Q3 2021.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Frontline position as of Q3 2021 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 61,662 Frontline shares in Q3 2021, an estimated $557K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Frontline in Q2 2020 and held it in 4 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Frontline position peaked at $6.72M in Q2 2020.
  • 123 funds tracked by Wall St. Rank held Frontline as of Q3 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2021, filed 12 Nov 2021.